An in vitro study showed that progesterone decreased CCR5 expression and increased CXCR4 expression in PBMCs of samples of patients both infected and uninfected with, suggesting that progesterone may modulate HIV infection at the receptor level by increasing the expression of HIV co-receptor CXCR4 [26,27]. This evidence concerns the gene AQP1 and HIV infectious disease.